The Insomnia Treatment No One Offered You

What first-line actually means

First-line is not a marketing word. It is the treatment a clinician is meant to reach for before any other, because it carries the strongest evidence and the best balance of benefit to harm. For chronic insomnia in adults, that treatment is cognitive behavioral therapy for insomnia. The American College of Physicians recommends that every adult with chronic insomnia disorder receive CBT-I as the initial treatment 1Ref 1Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians (2016).Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians.The ACP strongly recommends that all adults receive CBT-I as the first-line treatment for chronic insomnia disorder, with medication reserved for a shared decision only when CBT-I alone has not worked..

The American Academy of Sleep Medicine reaches the same conclusion from a separate review of the evidence, with a strong recommendation for multicomponent CBT-I 2Ref 2Edinger JD, Arnedt JT, Bertisch SM, et al. (2021).Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline.The AASM makes a strong recommendation for multicomponent CBT-I and recommends that sleep hygiene not be used as a standalone treatment for chronic insomnia.. Two independent bodies, different panels, the same answer — and neither of them puts a sleeping pill in that first slot. When a treatment earns a strong recommendation, it means the panel judged that the benefits clearly outweigh the harms for almost everyone the guidance covers, which is a high bar and a rare one.

For chronic insomnia, the guidelines name CBT-I — not a medication — as the first treatment to try.

So why didn't my doctor mention it?

If no one offered you CBT-I, that usually reflects how care is delivered rather than a judgment that it would not help you. A prescription takes one line on a pad and fits inside a short appointment. CBT-I takes a referral to a specifically trained provider, several sessions, and a clinician who knows the option exists and where to send you. Those frictions, not the evidence, are why medication so often comes first.

There are structural reasons underneath that. Many clinicians finished training before CBT-I became the guideline-endorsed first step, and providers trained in it are genuinely scarce outside major medical centers. Insomnia also has a way of surfacing at the very end of a visit that was booked for something else, when there is no time left to open a referral. None of that is a comment on you; it is the shape of a system that rewards the fast answer.

That so many people ended up on long-term sleeping pills is now itself a problem the field is trying to unwind. Deprescribing guidelines advise clinicians to offer to taper these medications, especially in adults over 65, where the risks of falls and daytime impairment climb — and they point to CBT-I as the alternative to move toward 3Ref 3Pottie K, Thompson W, Davies S, et al. (2018).Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.Deprescribing guidance recommends that clinicians offer to taper benzodiazepines and z-drugs used for insomnia, especially in adults 65 and older given falls and cognitive harms, and points to CBT-I as the alternative.. In other words, the treatment you may not have been offered is the same one clinicians are now being told to steer people back to.

What sleeping pills actually do

Sleeping pills work in a narrow sense: on the nights they are taken, they can shorten the time it takes to fall asleep and add a little total sleep. But the benefit is modest and short-lived, and it travels with harms — next-day grogginess, a higher risk of falls, and tolerance among them 4Ref 4Wilt TJ, MacDonald R, Brasure M, et al. (2016).Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.The evidence review documents that insomnia medications offer modest, mostly short-term benefit and carry adverse-event and harm signals.. A sedative quiets the brain for one night; it does not change the machinery that produces insomnia, so when the medication stops, the sleeplessness is usually still waiting.

This is the difference between treating a symptom and treating a condition. Whether sleeping pills for insomnia fix anything is the crux of the question, and the honest answer from the evidence is that they are symptomatic, not curative. The AASM's own guideline on insomnia medications gives only weak recommendations for the prescription hypnotics, and it suggests against several of the most popular remedies — melatonin, trazodone, diphenhydramine, and valerian — for chronic insomnia, citing little or insufficient evidence that they help 5Ref 5Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017).Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.The AASM drug guideline offers only weak recommendations for prescription hypnotics and suggests against melatonin, trazodone, diphenhydramine, and valerian for chronic insomnia on the basis of little or insufficient evidence..

None of this makes medication worthless. It means a pill is a bridge, not a destination, and that a treatment built to change the underlying pattern deserves to be tried first rather than last.

It is worth separating two claims people often blur. 'Sleeping pills do nothing' is false — they can help a hard night. 'Sleeping pills fix insomnia' is also false — they manage it only while it is taken. Holding both ideas at once is what the evidence supports, and it is what makes therapy the more sensible starting point rather than the last resort.

What CBT-I does instead

CBT-I is a short, structured program — usually four to eight sessions — that dismantles the specific habits and thoughts keeping insomnia going. It is not open-ended counseling about your past. It assembles a few concrete methods: resetting the time spent in bed to rebuild the body's pressure to sleep, breaking the learned link between the bed and lying awake frustrated, and loosening the racing, effortful thinking that shows up at 2am.

The pieces have names — stimulus control, sleep restriction, cognitive restructuring, and relaxation training. Sleep hygiene, the familiar advice about caffeine and screens, is a minor supporting player, and the guideline is explicit that sleep hygiene on its own is not a treatment for chronic insomnia 2Ref 2Edinger JD, Arnedt JT, Bertisch SM, et al. (2021).Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline.The AASM makes a strong recommendation for multicomponent CBT-I and recommends that sleep hygiene not be used as a standalone treatment for chronic insomnia.. It is one ingredient, not the recipe, and a page built entirely around it is not offering you the treatment.

Because CBT-I changes the pattern that maintains insomnia rather than sedating around it, it improves both overall insomnia severity and the night-to-night sleep measures people track in a diary 6Ref 6Brasure M, Fuchs E, MacDonald R, et al. (2016).Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.The behavioral evidence review finds that CBT-I improves global insomnia outcomes and sleep-diary measures in adults with chronic insomnia. — and those gains are meant to hold after the sessions end. That durability is the whole point, and it is the feature no medication can match.

Is it really better than a pill?

The evidence that sets CBT-I apart is durability. A medication helps only while it is being taken, and its benefit for insomnia is modest and short-term to begin with 4Ref 4Wilt TJ, MacDonald R, Brasure M, et al. (2016).Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.The evidence review documents that insomnia medications offer modest, mostly short-term benefit and carry adverse-event and harm signals.; the sleeplessness tends to return once the pills stop. CBT-I teaches skills that keep working after treatment ends, so on the question of CBT-I vs sleeping pills, the same-week relief can look similar while the lasting change belongs to therapy.

This is exactly why the guidelines sequence the two the way they do. The ACP recommends CBT-I first for every adult with chronic insomnia, and reserves adding medication for a shared decision made only when CBT-I alone has not been enough 1Ref 1Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians (2016).Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians.The ACP strongly recommends that all adults receive CBT-I as the first-line treatment for chronic insomnia disorder, with medication reserved for a shared decision only when CBT-I alone has not worked. — not medication first, with therapy as an afterthought. The ordering is deliberate, and it follows the evidence rather than the convenience of the prescription pad.

It is worth being precise about what this does and does not claim. It does not say pills never work or that a hard night should be white-knuckled. It says that when the goal is durable, self-sustaining sleep, the tested behavioral program is the stronger long-term bet, and the guidelines put it in front for that reason.

There is also a quieter benefit that never appears in a sleep-diary column: not having to weigh next-day grogginess, tolerance, or the recurring question of when to stop. A course of therapy ends; a nightly medication is an open-ended decision. For many people, closing that loop is part of why the guideline preference feels right in practice, not only on paper.

Who CBT-I is for — and when a pill still has a role

CBT-I is the first choice for chronic insomnia across most adults — including older adults, and people whose insomnia sits alongside depression, anxiety, or chronic pain, where it remains effective. It is also the preferred route for anyone who wants to avoid or come off medication, including CBT-I in pregnancy, when many people specifically want a treatment that is not a drug. Its reach is one of the reasons it sits at the front of the guidance rather than being reserved for a narrow group.

That does not make sleeping pills forbidden. A short course can bridge an acute crisis — a bereavement, a hospitalization, a stretch of shift work — or supplement therapy for someone who needs it. The guideline position is that medication is a considered choice made together with a clinician, at the lowest effective course, with a plan to reassess and taper later 3Ref 3Pottie K, Thompson W, Davies S, et al. (2018).Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.Deprescribing guidance recommends that clinicians offer to taper benzodiazepines and z-drugs used for insomnia, especially in adults 65 and older given falls and cognitive harms, and points to CBT-I as the alternative., rather than the automatic first move it has quietly become. Framed that way, CBT-I and medication are not rivals so much as a sequence, and the sequence starts with the treatment that changes the pattern.

What CBT-I does not fix

CBT-I is powerful precisely because it targets one thing well: the learned, self-perpetuating insomnia that keeps a rested body awake. It is the wrong tool when the real problem is a different sleep disorder wearing insomnia's clothes. Loud snoring with witnessed pauses in breathing can be obstructive sleep apnea; an irresistible urge to move the legs at night can be restless legs syndrome; a body clock shifted hours later than the world wants can be a circadian rhythm disorder.

Each of those needs its own evaluation and its own treatment, and pushing sleep-restriction rules onto them can miss the point or make things worse. This is one reason CBT-I usually begins with a sleep diary and a careful history: the assessment sorts genuine insomnia from these look-alikes before any technique starts. If sleep has never felt refreshing no matter how long it lasts, or a bed partner reports gasping and silence, that is a signal to widen the workup rather than narrow it to insomnia alone.

How to actually get CBT-I

Getting CBT-I often starts with naming it out loud. Asking a clinician directly for cognitive behavioral therapy for insomnia — by its name — tends to surface a referral that a general 'I can't sleep' conversation does not. It signals that you know the option exists and are asking for the specific, guideline-backed treatment rather than a prescription, and that small shift in wording changes the visit. Naming it also guards against being quietly rerouted to a sleep-hygiene handout, which is a fragment of the treatment rather than the whole of it.

Where trained providers are thin on the ground, digital CBT-I delivers the same core methods — the sleep-window work, the stimulus-control rules, the cognitive tools — through a structured app or website, and it has been tested in large trials. Between in-person specialists, primary-care clinicians who have taken it on, and these programs, finding a CBT-I provider is a solvable problem even far from a big-city sleep center.

The fuller how-to — directories, credentials, insurance, and what a first session looks like — is its own subject. The point here is narrower and worth sitting with: the treatment you may never have been offered is real, it is first-line by the agreement of independent expert panels, and it is gettable.